June 2013

Support For Fertility Preservation Is Now An AMA Policy!

Should insurance companies cover the expenses of fertility preservation when a young cancer patient is at risk of losing their fertility as a result of their treatment? This is what members of the Michigan delegation asked the American Medical Association (AMA) to support by lobbying for federal legislation that would require insurers to cover fertility preservation when cancer treatments could result in infertility. As a result of their efforts, the resolution was adopted.

The new AMA policy states two points: 1) Support payment for fertility preservation, and 2) lobby for appropriate federal legislation requiring payment for oncofertility. This new policy would treat infertility as a medical condition, or a treatment-related adverse side effect. In other words, the patient is not “choosing” to undergo in vitro fertilization, the cancer and/or its treatment make that decision for them if biological parenthood is at stake.

Original Article

New Surgical Probe Reduces Multiple Lumpectomies in Breast Cancer Patients

There’s a new “toy” in the surgical wing at the UC Irvine Medical Center that’s causing surgical oncologists to perform 56% less duplicate breast cancer surgeries.  It’s called MarginProbe, and it detects whether surgeons have removed all of a woman’s breast cancer cells during surgery, reducing the necessity of a second operation.  This sterile, handheld device sends electromagnetic signals to the bodily tissues surrounding a surgical incision, which are then transmitted and analyzed to determine whether any unhealthy tissue remains in the breast.

Original Article

Tomorrow: Virtual Grands Rounds Covers Hormones and Cancer

stika.cfmTomorrow, June 27th, we are excited to be hosting Catherine Stika, MD, Associate Professor of Obstetrics & Gynecology at Northwestern University’s Feinberg School of Medicine, for our Virtual Grand Rounds (VGR) at 10 AM CDT, entitled, “Hormonal impact of cancer treatment and management of hormonal symptoms in female cancer survivors.” Dr. Stika will discuss hormonal changes with follicle depletion, menopausal symptoms and their physiological changes, hormonal replacement options, and symptom relief for breast cancer patients. Dr.

Original Article

Are Emergency Contraceptive Pills Too Taboo for the Social Media Market?

Many women don’t have all the facts when unprotected sex occurs.  Emergency contraceptive methods represent evolving and scientifically viable options for many women, yet are not adequately marketed to the public.  Emergency Contraceptive Pills (EPCs) offer women a fast and private over-the-counter option to use after unprotected sex.  With the multitude of contraceptive agents on the market, EPCs would seemingly be added to the marketing of family planning initiatives.

Original Article

Certain Allergies More Prevalent in Women

Most people assume seasonal allergies are prevalent during the spring months, when pollen counts are high. While these types of allergies are a serious concern for many women that have them, women have unique challenges when it comes to allergies that men may not face.

It may take some work on your part, but once you understand the common allergens that affect most women, it is entirely possible to avoid the symptoms that these allergies cause.

Makeup

Original Article

Female Genital Mutilation: Analyzing its Culture and Consequences

Surfacing research proves the Sub-Saharan African traditions of Female Genital Mutilation and Female Genital Cutting (FGM/FGC) lead to long-term health consequences. Such health problems are found to impact the delivery and health of newborns.  Researchers and anthropologists from the Autonomus University of Barcelona collected data from 588 females in The Gambia.  Data were carefully gathered through questionnaires and physical examinations of the female patients, and analyzed with 95% confidence intervals.

Original Article

Archives